These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19281736)

  • 1. Prevalence of heparin-induced antibody in African-American hemodialysis patients--comparison to non-dialysis patients.
    Benjamin J; Moldavsky S; Lee J; Rubin R
    Clin Nephrol; 2009 Mar; 71(3):263-6. PubMed ID: 19281736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.
    Palomo I; Pereira J; Alarcón M; Díaz G; Hidalgo P; Pizarro I; Jara E; Rojas P; Quiroga G; Moore-Carrasco R
    J Clin Lab Anal; 2005; 19(5):189-95. PubMed ID: 16170812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced antibodies and cardiovascular risk in patients on dialysis.
    Asmis LM; Segal JB; Plantinga LC; Fink NE; Kerman JS; Kickler TS; Coresh J; Gardner LB
    Thromb Haemost; 2008 Sep; 100(3):498-504. PubMed ID: 18766268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical significance of heparin induced antibodies in chronic hemodialysis patients and cardiac surgery patients.
    Shavit L; Bar-Lev M; Lifschitz M; Fink D; Rudensky B; Slotki I
    Int J Artif Organs; 2011 Dec; 34(12):1172-8. PubMed ID: 22198603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.
    Nakamoto H; Shimada Y; Kanno T; Wanaka K; Matsuo T; Suzuki H
    Hemodial Int; 2005 Oct; 9 Suppl 1():S2-7. PubMed ID: 16223438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance and risk factors of anti-platelet factor 4/heparin antibody on maintenance hemodialysis patients: a two-year prospective follow-up.
    Zhao D; Sun X; Yao L; Lin H; Li J; Zhao J; Zhang Z; Lun L; Zhang J; Li M; Huang Q; Yang Y; Jiang S; Wang Y; Zhu H; Chen X
    PLoS One; 2013; 8(4):e62239. PubMed ID: 23646121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the antiheparin-platelet factor 4 antibody in hemodialysis (HD) patients and its effects upon dialysis access.
    Wallace K; Dasgupta I; Stratton J; Johnston P; Parry R
    Clin Nephrol; 2010 Nov; 74(5):409-10. PubMed ID: 20979952
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis.
    O'Shea SI; Sands JJ; Nudo SA; Ortel TL
    Am J Hematol; 2002 Jan; 69(1):72-3. PubMed ID: 11835336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients.
    Boonyawat K; Angchaisuksiri P; Aryurachai K; Chaiyaroj S; Ahmadi Z; Chong BH
    Thromb Res; 2014 Nov; 134(5):957-62. PubMed ID: 25204999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of heparin-platelet factor 4 antibodies as a marker of hypercoagulability during hemodialysis.
    Yu A; Jacobson SH; Bygdén A; Egberg N
    Clin Chem Lab Med; 2002 Jan; 40(1):21-6. PubMed ID: 11916267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin.
    Maharaj S; Chang S; Seegobin K; Morales J; Aysola A; Rana F; Shaikh M
    Exp Hematol Oncol; 2018; 7():23. PubMed ID: 30221035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with positive heparin-platelet factor-4 antibodies: A retrospective multi-institutional observational study.
    Tapan U; Bolla S; Daglilar ES; Chang S; Kozyreva O
    Platelets; 2015; 26(7):661-4. PubMed ID: 25383658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of and risk associated with aspirin therapy in hemodialysis patients with a background of antiplatelet factor 4/heparin complex antibody detection.
    Yang Y; Wang C; Jin L; Chen G; Li C; Qi K; Kong D; Wang Y; Song M; Ma L
    Thromb Res; 2015 Jul; 136(1):61-8. PubMed ID: 25936230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis.
    Son YB; Kim TB; Min HJ; Lee J; Yang J; Kim MG; Jo SK; Cho WY; Oh SW
    J Korean Med Sci; 2022 Mar; 37(10):e75. PubMed ID: 35289136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study.
    Pena de la Vega L; Miller RS; Benda MM; Grill DE; Johnson MG; McCarthy JT; McBane RD
    Mayo Clin Proc; 2005 Aug; 80(8):995-1000. PubMed ID: 16092577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis.
    Panzer S; Schiferer A; Steinlechner B; Drouet L; Amiral J
    Clin Chem Lab Med; 2015 Feb; 53(2):249-55. PubMed ID: 25153412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex.
    Carrier M; Rodger MA; Fergusson D; Doucette S; Kovacs MJ; Moore J; Kelton JG; Knoll GA
    Kidney Int; 2008 Jan; 73(2):213-9. PubMed ID: 17943076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
    Visentin GP; Ford SE; Scott JP; Aster RH
    J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.